These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 9083323

  • 41. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC, Rice A, Sangha ND, McCarty MA, Utterback R, Rohrback JM, Osborne BE, Fleischer AB, Feldman SR.
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [Abstract] [Full Text] [Related]

  • 42. Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol.
    Winkler UH, Ferguson H, Mulders JA.
    Contraception; 2004 Jun; 69(6):469-76. PubMed ID: 15157791
    [Abstract] [Full Text] [Related]

  • 43. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne.
    Toossi P, Farshchian M, Malekzad F, Mohtasham N, Kimyai-Asadi A.
    J Drugs Dermatol; 2008 Dec; 7(12):1149-52. PubMed ID: 19137768
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Hormonal treatment of acne: review of current best evidence.
    Tan J.
    J Cutan Med Surg; 2004 Dec; 8 Suppl 4():11-5. PubMed ID: 15778821
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial.
    Leyden J, Shalita A, Hordinsky M, Swinyer L, Stanczyk FZ, Weber ME.
    J Am Acad Dermatol; 2002 Sep; 47(3):399-409. PubMed ID: 12196750
    [Abstract] [Full Text] [Related]

  • 50. A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium.
    Leyden JJ, Bruce S, Lee CS, Ling M, Sheth PB, Stewart DM, Werschler WP, Gilbert RD, Kircik L.
    J Drugs Dermatol; 2013 Jun 01; 12(6):658-63. PubMed ID: 23839182
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Anti-androgen treatment of acne (author's transl)].
    Fanta D, Schneider WH, Spona J, Neufeld T.
    Wien Klin Wochenschr; 1977 Sep 30; 89(18):622-7. PubMed ID: 143797
    [Abstract] [Full Text] [Related]

  • 54. [Acceptance and subjective well-being with a norgestimate combination pill].
    Schoberberger R, Husslein P, Kunze M.
    Gynakol Rundsch; 1991 Sep 30; 31(2):65-76. PubMed ID: 1916521
    [Abstract] [Full Text] [Related]

  • 55. A randomized trial to evaluate the efficacy of online follow-up visits in the management of acne.
    Watson AJ, Bergman H, Williams CM, Kvedar JC.
    Arch Dermatol; 2010 Apr 30; 146(4):406-11. PubMed ID: 20404229
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
    Grinspoon SK, Friedman AJ, Miller KK, Lippman J, Olson WH, Warren MP.
    J Clin Endocrinol Metab; 2003 Aug 30; 88(8):3651-6. PubMed ID: 12915650
    [Abstract] [Full Text] [Related]

  • 58. [Medication of the month. Lowette, a contraceptive for treating acne in young women].
    Goffin V, Piérard-Franchimont C, Piérard GE.
    Rev Med Liege; 2003 Apr 30; 58(4):261-3. PubMed ID: 12868331
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The efficacy and tolerability of norgestimate/ethinyl estradiol (250 micrograms of norgestimate/35 micrograms of ethinyl estradiol): results of an open, multicenter study of 59,701 women.
    Runnebaum B, Grunwald K, Rabe T.
    Am J Obstet Gynecol; 1992 Jun 30; 166(6 Pt 2):1963-8. PubMed ID: 1605286
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.